Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Treatment and Outcome Analysis of 2,904 Pateints from the EUTOS Population Based Registry

Blood (2015) 126 (23): 2780.

https://doi.org/10.1182/blood.V126.23.2780.2780

Published: 2015

Journal Articles

The EUTOS Survival Score Is Preferable over the Sokal Score for Prognosis of Long-Term Survival of Patients with Chronic Myeloid Leukemia

Markus Pfirrmann, Joerg Hasford, MD, Susanne Saussele, Anna Turkina, Prof., MD, Witold Prejzner, MD, Juan Luis Steegmann, MD, Bengt Simonsson, MD, Andrey Zaritskey, MD, Adriana Colita, MD, Daniela Zackova, MD, Jeroen Janssen, MD, Francisco Cervantes, Karel Indrak, MD, Joelle Guilhot, PhD, Ruediger Hehlmann, MD, Michele Baccarani, MD

Blood (2015) 126 (23): 595.

https://doi.org/10.1182/blood.V126.23.595.595

Published: 2015

Journal Articles

Incidence of CML in Europe—a Comparison of 19 European Countries with US SEER Data

Blood (2014) 124 (21): 3145.

https://doi.org/10.1182/blood.V124.21.3145.3145

Published: 2014

Journal Articles

Baseline Characteristics of CML Patients Accross Europe - Comparing Real-World Patients with Patient Collectives Included in Clinical Trials

Blood (2014) 124 (21): 3160.

https://doi.org/10.1182/blood.V124.21.3160.3160

Published: 2014

Journal Articles

Prognostic Impact of Interim and Final PET in Primary Mediastinal Large B-Cell Lymphoma Treated with Intensive Etoposide-Based Therapy

Vít Procházka, MD, PhD, Lenka Henzlová, MD, Eva Buriánková, MD PhD, Zuzana Prouzová, MD, Ale Obr, MD, Martin Novák, Dr., Jiří Minařík, MD PhD, Karel Indrák, MD Prof., Tomá Papajík, MD PhD ass. prof.

Blood (2014) 124 (21): 1729.

https://doi.org/10.1182/blood.V124.21.1729.1729

Published: 2014

Journal Articles

CML Patients In Clinical Trials Represent Fairly Well The General Population Of CML Patients: A Comparative Analysis Of 5803 Patients From The EUTOS Registry

Verena S Hoffmann, PhD, Doris Lindoerfer, Dipl.-Inf., Markus Pfirrmann, PhD, Susanne Saussele, MD, Andreas Hochhaus, MD, Jutta Engel, PhD, MD, Joelle Guilhot, PhD, Gianantonio Rosti, Jiri Mayer, MD, PhD, Karel Indrak, MD, Fausto Castagnetti, Anna Turkina, Andrey Zaritskey, MD, PhD, Juan Luis Steegmann, MD, PhD, Andrzej Hellmann, Noortje Thielen, MD, Francisco Cervantes, MD, PhD, Bengt Simonsson, MD, PhD, Adriana Colita, MD, Richard E. Clark, MBBS, MD, FRCP, FRCPath, Antonio Almeida, MD, PhD, Boris Labar, MD, PhD, David Marin, MD, Gert J. Ossenkoppele, MD PhD, Andrija Bogdanovic, Irina Dyagil, Kimmo Porkka, MD, PhD, Stephen O'Brien, Laimonas Griskevicius, Panagiotis Panagiotidis, MD, Josef Thaler, MD, Irena Zupan, MD, PhD, Sandra Lejniece, PhD, MD, Hele Everaus, MD, PhD, Tamás Masszi, MD, PhD, Frederiki Melanthiou, Rüdiger Hehlmann, Joerg Hasford, MD, Michele Baccarani, MD

Blood (2013) 122 (21): 2735.

https://doi.org/10.1182/blood.V122.21.2735.2735

Published: 2013

Journal Articles

EUTOS Score Is Also Valid in CML Patients Not Involved in Clinical Studies

Verena S Hoffmann, MA., Jiri Mayer, MD, Anna G. Turkina, MD, PhD, Andrzej Hellmann, MD, Karel Indrak, MD, Prof., Juan Luis Steegmann, MD, Andrey Zaritskey, MD, Adriana Colita, MD, Doris Lindoerfer, Dipl.-Inf., Michele Baccarani, MD

Blood (2012) 120 (21): 3759.

https://doi.org/10.1182/blood.V120.21.3759.3759

Published: 2012

Journal Articles

Outcome of Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated with or without Rituximab

Heidi Mocikova, MD, PhD, Jozef Michalka, MD, Jan Koren, Pavla Stepankova, Alexander Wild, Ludek Raida, MD, Jana Markova, MD, Zdenek Kral, Marek Trneny, MD, Karel Indrak, MD, Prof., Jiri Mayer, M.D., PhD., Prof., Tomas Kozak, M.D., Ph.D.

Blood (2012) 120 (21): 4878.

https://doi.org/10.1182/blood.V120.21.4878.4878

Published: 2012

Journal Articles

Number of PD-1+/CD8+ Cells in Peripheral Blood of Patients with Lymphoma Reflects Tumor Burden, Lymphoma Subtype, Disease Phase and Is Significantly Higher Compared to Healthy Volunteers.

Vit Prochazka, M.D., Ph.D., Martin Novák, Dr., Zuzana Pikalova, Dr., Tomas Papajik, Dr., Ph.D., Karel Indrak, MD, Prof., Vladimir Divoky, Ph.D., ass. prof.

Blood (2012) 120 (21): 2670.

https://doi.org/10.1182/blood.V120.21.2670.2670

Published: 2012

Journal Articles

Programmed Death-1 Ligand Is Uniformly Expressed On Primary Mediastinal Diffuse Large B-Cell Lymphoma Cells with No Influence On Patient Survival.

Vit Prochazka, M.D., Ph.D., Tomas Papajik, Dr., Ph.D., Patrik Flodr, Dr., Pavla Latalova, Dr., Zuzana Prouzova, Dr., Radka Nedomova, Mgr., Marie Jarosova, Prof., Vladimir Divoky, Ph.D., ass. prof., Karel Indrak, MD, Prof.

Blood (2012) 120 (21): 2671.

https://doi.org/10.1182/blood.V120.21.2671.2671

Published: 2012

Journal Articles

Outcome of Patients with Chronic Myeloid Leukemia After Allogeneic Stem Cell Transplantation in Europe; Data From the EUTOS for CML Registry

Blood (2011) 118 (21): 1688.

https://doi.org/10.1182/blood.V118.21.1688.1688

Published: 2011

Journal Articles

Molecular Characterization of Hemoglobinopathies and Red Cell Enzymopathies in the Czech and Slovak Populations: An Update

Martina Divoka, Renata Mojzikova, Lucie Piterkova, Pavla Pospisilova, Martina Partschova, Monika Horvathova, Dagmar Pospisilova, Zuzana Laluhova Striezencova, Jaroslav Cermak, MD, PhD, Karel Indrak, Vladimir Divoky

Blood (2011) 118 (21): 5307.

https://doi.org/10.1182/blood.V118.21.5307.5307

Published: 2011

Journal Articles

Cytogenetic Aberration Profile of Chronic Myeloid Leukemia and Its Dynamic Changes During Imatinib Therapy,

Jelena D. Milosevic, Filip Razga, Dana Dvorakova, Tomas Jurcek, Tiina Berg, Ana Puda, Thorsten Klampfl, Ashot Harutyunyan, Bettina Gisslinger, Heinz Gisslinger, MD, Ester Orlandi, Paolo Bernasconi, Karel Indrak, Martina Divoka, Edgar Faber, Jiri Mayer, MD, Zdenek Racil, Robert Kralovics, PhD

Blood (2011) 118 (21): 3755.

https://doi.org/10.1182/blood.V118.21.3755.3755

Published: 2011

Journal Articles

Interferon Alpha Treated Patients with Chronic Myeloid Leukemia (CML) In Prolonged Complete Remission Have Increased Numbers of NK-Cells and Clonal Gamma-Delta T-Cells, and a Distinct Plasma Cytokine Profile.

Anna Kreutzman, MSc, Peter Rohon, MD, Edgar Faber, MD, PhD, Karel Indrak, MD, PhD, Vesa Juvonen, PhD, Veli Kairisto, MD, PhD, Jaroslava Voglova, MD, Marjatta Sinisalo, MD, PhD, Emilia Flochova, MD, PhD, Petteri Arstila, MD, PhD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD

Blood (2010) 116 (21): 1201.

https://doi.org/10.1182/blood.V116.21.1201.1201

Published: 2010

Journal Articles

Decreased Rate of β-Globin L1 Allele Transcription Due to Intronic LINE-1 Insertion In the β-Globin gene Is Associated with β-globin L1 Promoter and Enhancer Hypermethylation Which Is Not Reverted by Decitabine

Lucie Piterkova, Ing, Jana Kucerova, MSc, Karel Indrak, MD, PhD, Vladimir Divoky, PhD

Blood (2010) 116 (21): 2073.

https://doi.org/10.1182/blood.V116.21.2073.2073

Published: 2010

Journal Articles

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses – Population Based Analysis of 458 Patients Treated Between 2003–2009.

Blood (2010) 116 (21): 1239.

https://doi.org/10.1182/blood.V116.21.1239.1239

Published: 2010

Journal Articles

The European Treatment and Outcome Study (EUTOS) for Chronic Myeloid Leukemia (CML). A Prospective, Population-Based European Registry.

Blood (2009) 114 (22): 4272.

https://doi.org/10.1182/blood.V114.22.4272.4272

Published: 2009

Journal Articles

Imatinib Plasma Levels Correlate with Molecular Response in CML Patients

Sarka Rozmanova, Ms., David Friedecky, Ph.D., Adriana Polynkova, BC, Edgar Faber, MD, Peter Rohon, MD, Tomas Adam, Ph.D., Marie Jarosova, Karel Indrak, MD

Blood (2008) 112 (11): 4268.

https://doi.org/10.1182/blood.V112.11.4268.4268

Published: 2008

Journal Articles

JAK2 Mutation and Additional Thrombophilic Markers Predispose to Thrombosis in Myeloproliferative Diseases with Thrombocythemia

Miroslav Penka, Jiri Schwarz, Michael Doubek, MD, PhD, Petr Dulicek, Karel Indrak, Yvona Brychtova, MD, Antonin Hlusí, Jarmila Kissova, Jiri Mayer, MD, Tomas Pavlik

Blood (2008) 112 (11): 5257.

https://doi.org/10.1182/blood.V112.11.5257.5257

Published: 2008

NARROW

Treatment and Outcome Analysis of 2,904 Pateints from the EUTOS Population Based Registry

The EUTOS Survival Score Is Preferable over the Sokal Score for Prognosis of Long-Term Survival of Patients with Chronic Myeloid Leukemia

Incidence of CML in Europe—a Comparison of 19 European Countries with US SEER Data

Baseline Characteristics of CML Patients Accross Europe - Comparing Real-World Patients with Patient Collectives Included in Clinical Trials

Prognostic Impact of Interim and Final PET in Primary Mediastinal Large B-Cell Lymphoma Treated with Intensive Etoposide-Based Therapy

CML Patients In Clinical Trials Represent Fairly Well The General Population Of CML Patients: A Comparative Analysis Of 5803 Patients From The EUTOS Registry

EUTOS Score Is Also Valid in CML Patients Not Involved in Clinical Studies

Outcome of Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated with or without Rituximab

Number of PD-1+/CD8+ Cells in Peripheral Blood of Patients with Lymphoma Reflects Tumor Burden, Lymphoma Subtype, Disease Phase and Is Significantly Higher Compared to Healthy Volunteers.

Programmed Death-1 Ligand Is Uniformly Expressed On Primary Mediastinal Diffuse Large B-Cell Lymphoma Cells with No Influence On Patient Survival.

Outcome of Patients with Chronic Myeloid Leukemia After Allogeneic Stem Cell Transplantation in Europe; Data From the EUTOS for CML Registry

Molecular Characterization of Hemoglobinopathies and Red Cell Enzymopathies in the Czech and Slovak Populations: An Update

Cytogenetic Aberration Profile of Chronic Myeloid Leukemia and Its Dynamic Changes During Imatinib Therapy,

Interferon Alpha Treated Patients with Chronic Myeloid Leukemia (CML) In Prolonged Complete Remission Have Increased Numbers of NK-Cells and Clonal Gamma-Delta T-Cells, and a Distinct Plasma Cytokine Profile.

Decreased Rate of β-Globin L1 Allele Transcription Due to Intronic LINE-1 Insertion In the β-Globin gene Is Associated with β-globin L1 Promoter and Enhancer Hypermethylation Which Is Not Reverted by Decitabine

The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses – Population Based Analysis of 458 Patients Treated Between 2003–2009.

The European Treatment and Outcome Study (EUTOS) for Chronic Myeloid Leukemia (CML). A Prospective, Population-Based European Registry.

Management of Relapsed/Refractory Hodgkin Lymphomas After ASCT in Czech Republic.

Imatinib Plasma Levels Correlate with Molecular Response in CML Patients

JAK2 Mutation and Additional Thrombophilic Markers Predispose to Thrombosis in Myeloproliferative Diseases with Thrombocythemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only